Zyprexa

Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds

Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds

Xconomy

There is Life After Patent Expirations: Why Pfizer and Lilly Stocks Rebounded

There is Life After Patent Expirations: Why Pfizer and Lilly Stocks Rebounded

Forbes

Will What Happened to Lilly in 2012 Stay in 2012?

Will What Happened to Lilly in 2012 Stay in 2012?

Motley Fool

Some antipsychotics raise risks of death in dementia patients - study

Some antipsychotics raise risks of death in dementia patients - study

Pharma Times, UK

Eli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics

Eli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics

Bloomberg

FDA talks, but doctors don't necessarily listen

FDA talks, but doctors don't necessarily listen

Fierce Pharma

Pfizer and Eli Lilly face generic drugs challenge

Pfizer and Eli Lilly face generic drugs challenge

FT.com

Lilly’s Zyprexa $4.5 Million Pact With Health Providers Wins Approval Q

Lilly’s Zyprexa $4.5 Million Pact With Health Providers Wins Approval

Bloomberg

Lilly Wins First Trial Over Zyprexa Marketing

Lilly Wins First Trial Over Zyprexa Marketing

Pharmalot

Lilly Hid Zyprexa’s Diabetes Risks, Student Died, Lawyer Argues

Lilly Hid Zyprexa’s Diabetes Risks, Student Died, Lawyer Argues

Bloomberg